Little is known about how changes in dopaminergic neurotransmission in the sgACC might relate to development of depression in DLB, despite high levels of α-synuclein and other neurodegenerative pathology within the sgACC [28]. The gene discussed is SNCA; the disease is depressive symptom measurement.